Atracurium Besylate Injection, Solution
Product Images NDC 55150-217

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atracurium Besylate (NDC 55150-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg per 10 mL (10 mg / mL) [multi-use val])

This is a warning label and product information for Atracurium Besylate Injection, a sterile, non-pyrogenic medication used for intravenous injection. It is a paralyzing agent that can cause respiratory arrest, and facilities must have artificial respiration available immediately. The medication must be refrigerated and protected from light, and should be used within 14 days of removal from the refrigerator even if it is re-refrigerated. The medication contains Benzyl Alcohol and is provided in a 10 mL sterile multiple-dose vial.*

FDA Label Image

Package Label-principal Display Panel (100 mg per 10 mL (10 mg / mL) [multi-use vials])

This is a drug information sheet for Atracurium Besylate Injection, USP containing warnings, dosage information, and storage instructions. The drug is a paralyzing agent that can cause respiratory arrest, and facilities must have artificial respiration immediately available. The usual dosage should be followed as described in the package insert. It comes in 10 x 10 mL multiple-dose vials and must be used within 14 days, even if refrigerated. It is sterile and non-pyrogenic for intravenous injection and contains benzyl alcohol. The manufacturer is AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (10 mg/mL)

This appears to be a label for Atracurium Besylate Injection with instructions to peel off and apply to a syringe. It also states that the concentration is 10mg/mL and contains a product code (P1413528) and date/time information for when it was administered.*

FDA Label Image

Atracurium Besylate Chemical Structure (Atracurium Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.